Related by context. All words. (Click for frequent words.) 74 lipid parameters 72 lipid profiles 72 plasma lipids 71 inflammatory biomarkers 71 serum lipid 70 cardiometabolic risk 70 metabolite concentrations 70 serum PTH 70 β blockers 70 intima media thickness 70 glycemia 69 carotid IMT 69 HbA1C levels 69 fasting glucose levels 69 exploratory endpoints 68 leukocyte counts 68 atherogenic dyslipidemia 68 antitumor efficacy 68 glycated hemoglobin levels 68 fasting insulin 68 pharmacokinetic parameters 68 serum lipids 68 glycosylated hemoglobin HbA1c 68 triacylglycerol concentrations 68 CLA supplementation 68 pharmacodynamic parameters 68 cardiorespiratory fitness 68 adiponectin levels 68 telomere lengths 68 serum lipid levels 68 plasma triglycerides 67 glucose homeostasis 67 Secondary efficacy endpoints 67 colorectal adenoma 67 lipid levels 67 extrapyramidal symptoms 67 serum concentrations 67 HER2 expression 67 glomerular filtration 67 HbA 1c 67 biochemical markers 67 HbA1c levels 67 tHcy 67 serum cortisol 67 mRNA expression 67 plasma lipid 67 serum phosphate levels 67 albumin excretion 67 lipid lowering agents 67 Lp PLA 2 67 HbA 1c levels 67 hepatic enzymes 67 NPH insulin 67 thyrotropin 67 triacylglycerol 66 paricalcitol 66 apolipoprotein B 66 macrovascular events 66 intact parathyroid hormone 66 tertiles 66 hemoglobin A1c levels 66 neurocognitive function 66 pyridostigmine 66 serum calcium 66 sitosterol 66 serum triglycerides 66 abdominal adiposity 66 vasodilatation 66 thyrotropin levels 66 serum calcium levels 66 urinary excretion 66 antioxidant supplementation 66 glycosylated hemoglobin levels 66 pharmacokinetic PK profile 66 HOMA IR 66 d dimer 66 QTc intervals 66 erythropoietic 66 pleiotropic effects 66 fasting plasma 66 aminotransferases 66 androgen suppression 66 HRQL 66 dietary carbohydrate 66 prostate cancer CaP 66 serum creatinine levels 66 echocardiographic parameters 66 metabolic abnormalities 66 growth hormone secretion 66 liver histology 65 urate levels 65 covariate 65 fasting plasma glucose 65 urinary oxalate 65 albumin excretion rate 65 carotid artery thickness 65 TNFalpha 65 symptomatic VTE 65 arterial stiffness 65 peak VO2 65 LDL HDL 65 blood glucose concentrations 65 nonfasting triglyceride levels 65 plasma folate 65 QTc prolongation 65 surrogate markers 65 postoperative mortality 65 physiologic parameters 65 antidiabetic medications 65 serum phosphate 65 eosinophil count 65 receptor subtypes 65 serum leptin 65 homocysteine concentrations 65 prognostic significance 65 nondiabetic patients 65 serum cholesterol 65 metabolic disturbances 65 salivary cortisol 65 platelet reactivity 65 Cystatin C 65 morphometric vertebral fractures 65 cardioprotection 65 MMSE score 65 adrenal function 65 triglyceride concentrations 65 serotonin synthesis 65 F FDG PET 65 hemodynamic parameters 65 virologic responses 65 CVD mortality 65 p# activation 65 platelet activation 65 histologic subtypes 65 autonomic dysfunction 65 leptin concentrations 65 Subgroup analysis 64 timepoint 64 myocyte 64 gene polymorphisms 64 alanine aminotransferase ALT 64 airway hyperresponsiveness 64 tumor necrosis 64 serum PSA 64 sulphonylureas 64 diastolic function 64 timepoints 64 electrophysiologic 64 APOE genotype 64 locomotor activity 64 Tasigna prolongs 64 triiodothyronine 64 cystatin C 64 Insulin sensitivity 64 ABCB1 64 hemoglobin Hb 64 Subgroup analyzes 64 lipid abnormalities 64 dosage regimens 64 vascular reactivity 64 hippocampal volume 64 secondary efficacy endpoints 64 pharmacodynamic endpoints 64 HAQ DI 64 inflammatory markers 64 pCR 64 elevated creatinine 64 cardiovascular morbidity 64 ejection fractions 64 conditional logistic regression 64 extrapyramidal symptoms EPS 64 Logistic regression 64 AST ALT 64 atheroma volume 64 isotypes 64 hepatic glucose production 64 adiponectin concentrations 64 K ras mutations 64 Secondary endpoints 64 aspartate aminotransferase AST 64 interleukin IL -6 64 airway responsiveness 64 baseline LDH 64 hematologic parameters 64 hematological parameters 64 tissue oxygenation 64 left ventricular diastolic 64 CIMZIA ™ 64 leukocyte count 64 prolactin levels 64 cardioprotective effects 64 fasting plasma glucose FPG 64 glomerular filtration rate 64 serum glucose 64 plasma pharmacokinetics 64 serum homocysteine 64 troponin T 64 macrophage infiltration 64 serum markers 64 IFN beta 64 HAART regimens 64 QT intervals 64 neutrophil counts 64 HPA axis 64 lactate dehydrogenase 64 plasma glucose 64 serum BDNF 64 graft occlusion 64 hyperglycaemia 64 pharmacodynamic effects 64 HIV HCV coinfected 64 elevated triglyceride levels 64 visceral adiposity 64 antidiabetic drugs 64 hepatic function 64 cardiac contractility 64 peripheral insulin sensitivity 64 Primary endpoints 64 Triglyceride levels 64 T2DM 63 visceral fat accumulation 63 multivariate logistic regression 63 serum urate 63 fructosamine 63 micronuclei 63 virological response 63 Hb A1C 63 aspartate aminotransferase 63 cerebral perfusion 63 tolvaptan 63 CPAP adherence 63 riociguat 63 capillary density 63 serum IGF 63 urine albumin 63 oxcarbazepine 63 adiposity 63 angiotensin II receptor blockers 63 central corneal thickness 63 Leydig cell 63 pathophysiological mechanisms 63 ovarian hormones 63 antiplatelet drugs 63 hsCRP levels 63 lipid lowering therapies 63 dietary intakes 63 postprandial glycemia 63 adipokines 63 flow mediated dilation 63 fibrinolysis 63 alkaline phosphatase ALP 63 RBP4 63 hsCRP 63 fluvastatin 63 covariates 63 PSADT 63 improves glycemic 63 pulmonary arterial 63 bezafibrate 63 QRS duration 63 urinary calcium 63 insulin detemir 63 plasma fibrinogen 63 central adiposity 63 apolipoproteins 63 rCBF 63 thyroid hormone levels 63 histone modifications 63 perioperative complications 63 angiographic outcomes 63 hypericin 63 ATACAND 63 lymphocyte counts 63 antihypertensive medications 63 parasympathetic tone 63 solifenacin 63 serum uric acid 63 PASI scores 63 tolerability profiles 63 multivariate analyzes 63 apo B 63 IL 1ß 63 contractility 63 serum bicarbonate 63 serum albumin 63 statin monotherapy 63 db db mice 63 CTAP# Capsules 63 glycogen metabolism 63 μmol L 63 lipoprotein Lp 63 antidepressants SSRIs 63 PON1 63 ERK signaling 63 pharmacokinetic characteristics 63 serum retinol 63 coinfected patients 63 somatostatin analogs 63 subclinical atherosclerosis 63 thyroid stimulating hormone 63 LDL cholesterol concentrations 63 genes CYP#C# 63 IGFBP 63 APTIVUS r 63 diastolic BP 63 logistic regression analyzes 63 spirometric 63 coadministration 63 protein excretion 63 mTOR inhibitors 63 Cardiorespiratory fitness 63 carbohydrate metabolism 63 artery stenosis 63 INCB# [003] 63 dyslipidaemia 63 glucose insulin 63 radiosensitivity 63 IPAH 63 GFT# 63 endometrial hyperplasia 63 troponins 63 insulin sensitizing 63 fosamprenavir 63 tranylcypromine 63 multivariable analysis 63 atypical neuroleptics 63 probiotic supplementation 63 inotropic 63 metabolizing enzyme 63 antidepressant efficacy 63 STRIDE PD 63 T1DM 63 Ramipril 63 baroreflex sensitivity 63 somatic symptoms 63 NHANES III 63 fibrin deposition 63 anthropometric measures 63 concomitant medications 63 mechanistic studies 63 coronary stenoses 63 biochemical abnormalities 63 antibody titer 63 alanine aminotransferase 63 mitochondrial metabolism 63 arterial stiffening 63 5 HT2C receptor 63 clomipramine 63 multivariate Cox 63 coronary stenosis 63 microvascular complications 63 TPMT 62 plasma leptin 62 estrone 62 ERalpha 62 SGPT 62 Baseline characteristics 62 BENICAR HCT 62 mu opioid 62 bone metabolism 62 transaminase levels 62 glycaemia 62 systolic function 62 cardiac dysfunction 62 androgen deprivation 62 nondiabetic subjects 62 LDL cholesterol lowering 62 GH deficiency 62 serum potassium 62 endocannabinoid signaling 62 intestinal microflora 62 calculated creatinine clearance 62 left ventricular LV 62 #F FDG PET 62 postprandial glucose 62 MDRD 62 T2 lesions 62 platelet inhibition 62 mammographic density 62 pharmacodynamic markers 62 immunoreactivity 62 hemodynamics 62 GRNCM1 62 prospectively defined 62 adenoma recurrence 62 neurodevelopmental outcome 62 inhibitory neurotransmitters 62 TEAEs 62 Cognitive impairment 62 flutamide 62 HepG2 cells 62 chest radiographs 62 Pioglitazone 62 eplerenone 62 antihypertensive therapy 62 genotypic resistance 62 Angiotensin converting enzyme 62 hyperalgesia 62 baseline HbA1c 62 pressure natriuresis 62 pharmacokinetic profiles 62 cardiac repolarization 62 atherogenic lipids 62 RAS blockers 62 lipoprotein levels 62 lactate dehydrogenase LDH 62 Pharmacokinetic parameters 62 olmesartan 62 serum vitamin D 62 acarbose 62 diastolic pressures 62 DNA methylation patterns 62 cortical activation 62 univariate analyzes 62 submaximal 62 direct thrombin inhibitors 62 irbesartan 62 intima media thickness IMT 62 endometrial thickness 62 Platelet counts 62 loop diuretics 62 genetic polymorphisms 62 induced sputum 62 dobutamine 62 secondary efficacy endpoint 62 corrected QT interval 62 lowering blood glucose 62 SGRQ 62 glycated hemoglobin HbA1c 62 paclitaxel eluting stents 62 isoenzyme 62 glitazones 62 glucose lowering 62 microglial activation 62 Akt activation 62 circulating endothelial cells 62 neurohormones 62 antiplatelet therapies 62 cardiac biomarkers 62 immunological responses 62 subclinical hypothyroidism 62 mesalamine granules 62 antithrombotic 62 hemorrhagic complications 62 blood lipids 62 skeletal muscle mass 62 serum estradiol 62 adjuvant therapies 62 acromegalic patients 62 ionotropic 62 A1c levels 62 serum TSH 62 metabolic syndrome MetS 62 GSTP1 62 serum ferritin 62 NNT = 62 hemoglobin A1c HbA1c 62 leptin deficient mice 62 mdx mice 62 postintervention 62 intensive statin therapy 62 immunosuppressive regimen 62 systolic dysfunction 62 serum triglyceride levels 62 antiemetics 62 posttreatment 62 myocardial ischemia 62 cranial irradiation 62 CaPre ™ 62 glucose tolerance 62 cognitive domains 62 LV ejection fraction 62 pharmacological approaches 62 neuropsychiatric symptoms 62 oral antidiabetic agents 62 hypoperfusion 62 tryptase 62 ACh 62 cardio respiratory fitness 62 Genetic variants 62 urinary protein 62 somatostatin 62 logistic regression model 62 atherogenic 62 KRAS status 62 lymphocyte count 62 sweat chloride 62 myopathy rhabdomyolysis 62 APOC3 62 HbA1C 62 cardiac autonomic 62 normotensive 62 hypotensive 62 PAOD 62 SUVmax 62 highest tertile 62 VADT 62 diastolic blood pressures 62 ADCS ADL 62 monoclonal gammopathy 62 bosentan 62 bile acid metabolism 62 serum aminotransferase levels 62 FDG uptake 62 Thyroid hormone 62 lispro 62 pharmacodynamic PD 62 muscle protein synthesis 62 dysglycemia 62 IgG4 62 oncologic outcomes 62 endogenous hormones 62 transgene expression 62 cardioprotective effect 62 plasma renin activity 62 differential gene expression 62 mitochondrial biogenesis 62 carbohydrate oxidation 62 fat oxidation 62 subgroup analyzes 62 lumbar spine BMD 62 antidiabetic medication 62 systolic hypertension 62 serum urate levels 62 infarct size 62 Fasting plasma glucose 62 psychosocial variables 62 antigen PSA levels 62 myocardial uptake 62 interferon IFN 62 CagA 62 confounding variables 62 carotid bruit 62 hemodilution 62 PPAR agonist 62 carotid plaque 62 teriflunomide 62 antiviral efficacy 62 prognostic variables 62 dopamine neuron 62 immunostaining 62 androgen blockade 62 baroreceptor 62 glycated hemoglobin 62 creatine kinase 62 tumor histology 62 flecainide 62 postoperative AF 62 hepatoma 62 umol L 62 antihypertensive drugs 62 glycosylated hemoglobin 62 achieved statistical significance 62 zoledronate 61 cortisol secretion 61 contractile function 61 adenotonsillectomy 61 HRQOL 61 thyroid stimulating hormone TSH 61 eculizumab therapy 61 MGd 61 VKORC1 61 glucose concentrations 61 antiandrogens 61 methylation patterns 61 MADRS score 61 improves insulin sensitivity 61 BMI z 61 urinary albumin 61 insulin sensitivity 61 pentoxifylline 61 NMDA antagonists 61 hamartomas 61 creatinine levels 61 macrovascular complications 61 glomerular 61 interstitial fluid 61 monocyte chemoattractant protein 61 GH secretion 61 trastuzumab Herceptin ® 61 MetS 61 plasma homocysteine 61 linoleic acid LA 61 CaPre TM 61 scintigraphic 61 selenium supplementation 61 insulin sensitizers 61 MMSE scores 61 OADs 61 polyp recurrence 61 metformin sulfonylurea 61 pulmonary capillary wedge 61 tyrosine phosphorylation 61 glucose metabolism 61 selective modulator 61 vidofludimus 61 impaired glucose metabolism 61 cellularity 61 UGT#A# * 61 FOSRENOL ® 61 CEACAM1 61 convergent validity 61 HER2 overexpression 61 natriuretic peptides 61 hemoglobin A1C 61 macrovascular disease 61 EGFR expression 61 magnesium intake 61 Fasting glucose 61 rhGH 61 tumor perfusion 61 Natalizumab 61 Secondary endpoints included 61 myocardial reperfusion 61 STAT3 signaling 61 pharmacodynamic properties 61 plasma creatinine 61 arachidonic acid AA 61 hyperinsulinemic euglycemic clamp 61 RBP4 levels 61 baroreflex 61 parasitemia 61 hormones leptin 61 oral antidiabetic medication 61 hyperoxia 61 randomized controlled trials RCTs 61 QTc 61 receptor blockers 61 SHBG levels 61 unresectable HCC 61 Plasma concentrations 61 ApoA1 61 carotid intima media 61 ventricular enlargement 61 serum phosphorous 61 poor metabolizers 61 axillary lymph nodes 61 parietal cortices 61 NYHA functional class 61 transthyretin 61 aminotransferase levels 61 parathyroid hormone PTH 61 denervation 61 aminotransferase 61 fasting triglycerides 61 autoantibody levels 61 muscarinic receptors 61 renal toxicity 61 nicardipine 61 nonfasting 61 circadian genes 61 TIMP 1 61 adipocyte 61 serum parathyroid hormone 61 proinflammatory mediators 61 prognostic markers 61 hypothalamic pituitary 61 diabetes dyslipidemia 61 albuminuria 61 tHcy concentrations 61 relapsed MM 61 CYP#C# [001] 61 urine cytology 61 #ß 61 diuretic chlorthalidone 61 N telopeptide 61 exhaled nitric oxide 61 elevated triglycerides 61 HMG CoA reductase inhibitors 61 sonographic diagnosis 61 prostate carcinogenesis 61 fatty acid oxidation 61 glycogen synthesis 61 Clusterin 61 nelfinavir 61 periprocedural MI 61 hemoglobin concentrations 61 PCWP 61 prognostic indicators 61 radiographic findings 61 explanatory variables 61 comorbid conditions 61 bone resorption 61 tertile 61 isoprostane 61 Randomized trials 61 QTc interval 61 enzyme inhibition 61 rosuvastatin Crestor 61 #mg/day [002] 61 F FDG uptake 61 Cochrane reviewers 61 fibrotic disease 61 LHRH agonists 61 metabolic dysfunction 61 renal tubular 61 cardio metabolic 61 histopathological 61 liver transplant recipients 61 statins cholesterol lowering 61 brachial artery flow 61 pharmacodynamic 61 pioglitazone HCl 61 co morbidities 61 Meta analyzes 61 glucocorticoid hormones 61 lipid concentrations 61 physiological parameters 61 nephrotoxicity 61 endothelial activation 61 recurrent venous thromboembolism 61 μg kg 61 PTHrP 61 nondepressed 61 creatine supplementation 61 insulin resistance syndrome 61 detrusor 61 primidone 61 immunohistochemical staining 61 abnormal glucose tolerance 61 IGFBP 3 61 impaired endothelial 61 biochemical recurrence 61 nucleotide substitutions 61 neuropathologic 61 hemoglobin concentration 61 hypertensives 61 hypoglycemic events 61 catabolism 61 TT genotype 61 unmeasured factors 61 carotid artery intima media 61 atherogenesis 61 elevated uric acid 61 Lipoic acid 61 Hemoglobin A1c 61 psychopathological symptoms 61 thickness CIMT 61 arterial thickening 61 motor neuron degeneration 61 nutlin 3a 61 transaminases 61 bioavailable testosterone 61 colorectal carcinogenesis 61 carcinoids 61 ACE inhibitor ramipril 61 intestinal permeability 61 arteriolar 61 mycophenolate mofetil 61 hypoglycemic episodes 61 autophagic 61 neurite outgrowth 61 haematologic 61 paroxetine Paxil 61 hepatorenal syndrome 61 thromboembolic complications 61 CC genotype 61 idraparinux 61 PSA nadir 61 preoperative chemotherapy 61 lipid lowering therapy 61 periprocedural 61 neurodevelopmental outcomes 61 neurologic progression 61 antiangiogenic therapy 61 cerebral microbleeds 61 pulmonary artery pressure 61 salivary flow 61 apoA 61 dietary supplementation 61 amisulpride 61 lumbar spine bone 61 SCr 61 Multivariate analysis 61 mGluR2 NAM 61 alexithymia 61 dietary fatty acids 61 dose atorvastatin 61 creatinine ratio 61 urodynamic 61 ADAS cog 61 abnormal lipid 61 univariate 61 pharmacologic intervention 61 genetic loci 61 salmeterol fluticasone 61 elevated LDH 61 oral antidiabetic drugs 61 receptor inhibitor 61 posaconazole 61 antidiabetic drug 61 immunomodulation 61 bronchoalveolar lavage 61 angiotensin converting enzyme 61 Univariate 61 hyperhomocysteinemia 61 adrenalectomy 61 miRNA expression 61 p = #.# [003] 60 primary aldosteronism 60 RRM1 60 HbA 1C 60 neurologic outcomes 60 waist girth 60 curcuminoids 60 adrenal suppression 60 TNFa 60 NNRTI resistance 60 Crohn Disease Activity 60 serum biomarkers 60 oxysterols 60 murine model 60 normoxic 60 cortisol concentrations 60 nonpharmacologic 60 rHuEPO 60 onset diabetes mellitus 60 antioxidative 60 pramlintide metreleptin combination 60 CLA isomers 60 pressor response 60 metabolic acidosis 60 methacholine challenge 60 hepatic lesions 60 Endothelial dysfunction 60 analgesic efficacy 60 abnormal lipid levels 60 fasting glucose 60 HMG CoA reductase inhibitor 60 unmeasured confounders 60 busulfan 60 metabolic 60 posttransplant 60 dopamine D2 receptor 60 inhaled budesonide 60 multivariate regression analysis 60 Hypotension 60 extramedullary 60 ALB # 60 Symptom severity 60 symptom exacerbation 60 seminomas 60 daily subcutaneous injections 60 glatiramer acetate 60 microcirculatory 60 HDL cholesterol triglycerides 60 mineral density 60 Tasimelteon 60 ARB telmisartan 60 cerebrovascular events 60 intracranial hemorrhage ICH 60 hMG 60 trans retinoic acid 60 carotid atherosclerosis 60 vitro cytotoxicity 60 ritonavir boosted 60 IFN α 60 dose dependently 60 nonalcoholic steatohepatitis NASH 60 INVEGA ® 60 conjugated estrogen 60 gastric carcinogenesis 60 CYP#C# [002] 60 conventional angiography 60 hepatic insulin sensitivity 60 μg liter 60 gene polymorphism 60 Endothelial function 60 VEGF expression 60 desvenlafaxine succinate 60 heterozygotes 60 deferiprone 60 decrements 60 antihyperglycemic 60 virologic response 60 angiographically 60 glucocorticoid 60 pulmonary exacerbations 60 NIHSS 60 myocardial viability 60 trials RCTs 60 serum HCV RNA 60 PDGFR 60 hydroxyvitamin D levels 60 serum sodium 60 estrogen metabolites 60 Hcy 60 Logistic regression analysis 60 breast carcinoma 60 #.#mmol L [002] 60 antiepileptic drugs AEDs 60 rosuvastatin #mg 60 intravenous dosing 60 antiangiogenic activity 60 IFN gamma 60 act synergistically 60 perfusion abnormalities 60 lymphocytosis 60 cholinergic tone 60 prucalopride 60 type2 diabetes 60 Erythropoietic therapies may 60 collagenous colitis 60 prostanoid 60 detemir 60 5 hydroxytryptamine 60 fasting serum 60 Calcium intake 60 androgenic 60 intestinal absorption 60 LDL particle 60 elevated ALT 60 S#A# [002] 60 eicosanoids 60 Symadex 60 arterial oxygen saturation 60 prognostic factors 60 serum antibodies 60 bronchoalveolar lavage fluid 60 prostaglandin E 60 hormone secretion 60 metabolizing enzymes 60 differentially expressed genes 60 acetabular dysplasia 60 AZT zidovudine Retrovir 60 endothelial function 60 immunohistochemical 60 cystatin 60 IL #p# 60 hematologic toxicity 60 potassium sparing diuretics 60 neuroimaging studies 60 plasma glucose concentration 60 antiarrhythmic medications 60 vildagliptin 60 Bisphosphonate 60 CYP #A# 60 FGFs 60 microsomal 60 Carvedilol 60 sotalol 60 aldosterone hormone 60 peptide YY 60 Univariate analysis 60 oxidative stress markers 60 univariate analysis 60 intestinal motility 60 PSA kinetics 60 Doxil ® 60 prolactin elevation 60 cMET 60 ACEIs 60 adipogenic 60 neurohormonal 60 platelet function 60 phenelzine 60 miR #a [001] 60 candesartan cilexetil 60 EGFR HER2 60 antibody mediated 60 interleukin IL -# 60 E selectin 60 anticholinergic agents 60 plasma cortisol 60 otamixaban 60 pharmacologic treatments 60 Thiazolidinediones 60 L lysine 60 MDRD equation 60 inhibit platelet aggregation 60 overt hypothyroidism 60 NAbs 60 polytherapy 60 abdominal visceral fat 60 nonischemic 60 exendin 4 60 Depressive symptoms 60 shorter telomere length 60 pulmonary metastases 60 antitumor effects 60 corticosteroid dose 60 hypothalamic pituitary adrenal axis 60 intestinal epithelium 60 comorbid depression 60 CORE OM 60 TZDs 60 efficacy endpoint 60 fibrate drugs 60 hip circumference 60 ischaemia 60 Efficacy endpoints 60 CONCERTA ® 60 ACTOS ® 60 neurocognitive deficits 60 calcium homeostasis 60 prednisone prednisolone 60 amyloid plaque formation 60 UCP2 60 lipoprotein metabolism